WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax of $500.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), adjustments, tax for the quarter ending 2025-03-31 was $900.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), adjustments, tax for the quarter ending 2024-12-31 was -$1.60M, a 633.33% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), adjustments, tax for the quarter ending 2024-09-30 was $1.10M, a 37.50% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), adjustments, tax for the quarter ending 2024-06-30 was $300.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), adjustments, tax for fiscal 2025 was $500.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), adjustments, tax for fiscal 2024 was -$900.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), adjustments, tax for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), adjustments, tax for fiscal 2022 was $200.00K, a 60.00% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax 3 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax 6 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax 9 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $500.00K 10-K · filed 2026-02-17 | |||
| 2025-03-31 | $900.00K 10-Q · filed 2025-04-24 | -$700.00K derived: sum of 2 quarters · filed 2026-02-17 | $400.00K derived: sum of 3 quarters · filed 2026-02-17 | $700.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$500.00K derived: sum of 2 quarters · filed 2026-02-17 | -$200.00K derived: sum of 3 quarters · filed 2026-02-17 | -$900.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $1.10M 10-Q · filed 2024-10-24 | $1.40M derived: sum of 2 quarters · filed 2024-10-24 | $700.00K 10-Q · filed 2024-10-24 | $1.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $300.00K 10-Q · filed 2024-07-25 | -$400.00K 10-Q · filed 2024-07-25 | -$100.00K derived: sum of 3 quarters · filed 2026-02-17 | $700.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | -$700.00K 10-Q · filed 2025-04-24 | -$400.00K derived: sum of 2 quarters · filed 2026-02-17 | $400.00K derived: sum of 3 quarters · filed 2026-02-17 | -$600.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.10M derived: sum of 2 quarters · filed 2026-02-17 | $100.00K derived: sum of 3 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 |
| 2023-09-30 | $800.00K 10-Q · filed 2024-10-24 | -$200.00K derived: sum of 2 quarters · filed 2024-10-24 | -$300.00K 10-Q · filed 2024-10-24 | $700.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | -$1.00M 10-Q · filed 2024-07-25 | -$1.10M 10-Q · filed 2024-07-25 | -$100.00K derived: sum of 3 quarters · filed 2025-02-18 | -$100.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | -$100.00K 10-Q · filed 2024-04-25 | $900.00K derived: sum of 2 quarters · filed 2025-02-18 | $900.00K derived: sum of 3 quarters · filed 2025-02-18 | $900.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.00M derived: sum of 2 quarters · filed 2025-02-18 | $1.00M derived: sum of 3 quarters · filed 2025-02-18 | $200.00K 10-K · filed 2025-02-18 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-26 | $0.00 derived: sum of 2 quarters · filed 2023-10-26 | -$800.00K 10-Q · filed 2023-10-26 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-07-27 | -$800.00K 10-Q · filed 2023-07-27 | ||
| 2021-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $500.00K derived: sum of 2 quarters · filed 2024-02-20 | $1.30M derived: sum of 3 quarters · filed 2024-02-20 | $500.00K 10-K · filed 2024-02-20 |
| 2021-09-30 | -$400.00K 10-Q · filed 2022-10-27 | $400.00K derived: sum of 2 quarters · filed 2022-10-27 | -$400.00K 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $800.00K 10-Q · filed 2022-07-28 | $0.00 10-Q · filed 2022-07-28 | ||
| 2020-09-30 | -$200.00K 10-Q · filed 2021-10-28 | -$1.70M derived: sum of 2 quarters · filed 2021-10-28 | -$400.00K 10-Q · filed 2021-10-28 | |
| 2020-06-30 | -$1.50M 10-Q · filed 2021-07-30 | -$200.00K 10-Q · filed 2021-07-30 | ||
| 2019-06-30 | $800.00K 10-Q · filed 2020-07-24 | -$800.00K 10-Q · filed 2020-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |